
Physical inactivity costs the U.S. $192B annually; the first FDA-targeted hangover therapy advances to Phase 2 trials; living near the ocean could add years to your life – Morning Medical Update
Key Takeaways
- Physical inactivity accounts for 12.6% of U.S. healthcare spending, prompting calls for systemic reforms to encourage daily movement.
- SJP-001, a hangover prevention therapy targeting inflammation, is in Phase 2 trials and could become the first FDA-approved treatment.
The top news stories in medicine today.
A new study published in the
“We’re spending nearly one out of every eight health care dollars on something we can prevent,” said Michael Stack, ACSM-EP, president of the Physical Activity Alliance.
Sen-Jam Pharmaceutical has launched Phase 2 trials in Canada for SJP-001, a
A new Ohio State study in
Newsletter
Stay informed and empowered with Medical Economics enewsletter, delivering expert insights, financial strategies, practice management tips and technology trends — tailored for today’s physicians.


















